دورية أكاديمية

Holter Monitoring (24-Hour ECG) Parameter Dynamics in Patients with Ischemic Heart Disease and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.

التفاصيل البيبلوغرافية
العنوان: Holter Monitoring (24-Hour ECG) Parameter Dynamics in Patients with Ischemic Heart Disease and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.
المؤلفون: Fiev DN; Institute for Urology and Human Reproductive Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Vinarov AZ; Institute for Urology and Human Reproductive Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia. avinarov@mail.ru., Tsarichenko DG; Institute for Urology and Human Reproductive Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Kopylov PY; Institute of Personalized Medicine, Sechenov University, Moscow, Russia., Demidko YL; Institute for Urology and Human Reproductive Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Syrkin AL; Department of Preventive and Emergency Cardiology, Sechenov University, Moscow, Russia., Rapoport LM; Institute for Urology and Human Reproductive Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Alyaev YG; Institute for Urology and Human Reproductive Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Glybochko PV; Institute for Urology and Human Reproductive Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
المصدر: Advances in therapy [Adv Ther] 2019 Aug; Vol. 36 (8), pp. 2072-2085. Date of Electronic Publication: 2019 May 30.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther
أسماء مطبوعة: Publication: New York : Springer Healthcare Communications, 2008- : Health Communications Inc.
Original Publication: Metuchen, N.J. : Health Communications Inc., c1984-
مواضيع طبية MeSH: Adrenergic alpha-1 Receptor Antagonists/*blood , Electrocardiography, Ambulatory/*methods , Lower Urinary Tract Symptoms/*diagnosis , Myocardial Ischemia/*diagnosis , Prostatic Hyperplasia/*complications , Tamsulosin/*therapeutic use , Urethral Obstruction/*drug therapy, Aged ; Aged, 80 and over ; Humans ; Lower Urinary Tract Symptoms/blood ; Lower Urinary Tract Symptoms/etiology ; Male ; Middle Aged ; Myocardial Ischemia/blood ; Myocardial Ischemia/etiology ; Prostatic Hyperplasia/blood ; Russia ; Urethral Obstruction/diagnosis ; Urethral Obstruction/etiology ; Urological Agents/therapeutic use
مستخلص: Introduction: This study examined the dynamics of 24-h electrocardiogram (ECG) monitoring parameters (Holter monitoring) in patients with ischemic heart disease (IHD) before and after conservative or surgical treatment of patients with voiding and storage lower urinary tract symptoms (LTS) due to benign prostatic hyperplasia (BPH).
Methods: A total of eighty-three 57 to 81-year-old (mean age 70.4 ± 5.75 years) patients with LUTS/BPH and accompanying IHD were examined and treated at the Institute of Urology and Human Reproductive Health and Clinic of Cardiology of Sechenov University. All patients received recommended cardiac therapy at least 6 months before inclusion in the study.
Results: Our study demonstrated that there is correlation between voiding and storage LUTS/BPH and Holter-detected cardiac impairments in patients with IHD/BPH. These data make it possible to consider LUTS/BPH (voiding and storage) as a factor in the additional functional and psychological load on the activity of patients with ischemic heart disease. Improvement of voiding and storage LUTS due to BPH and objective parameters of urination (Q max ) in patients treated with alpha-1 adrenoceptor blocker tamsulosin correlated with improvement of 24-h ECG monitoring parameters (Holter monitoring) in 72% of patients. Improvement of 24-h ECG monitoring parameters (Holter monitoring) 1 month after transurethral resection of the prostate (TURP) in IHD/BPH patients and indications for surgical treatment was observed in 65.7%. Negative dynamics of the Holter-based ECG was not registered in patients who were operated on.
Conclusion: Holter monitoring helps to identify groups of patients in whom urinary impairments caused by prostatic hyperplasia negatively affect the course of IHD. Restored urination (either conservatively or operatively) in patients with BPH in 72% of cases decreased the number of fits of angina, thus influencing favourably the course of IHD.
Trial Registration: ClinicalTrials.gov Identifier: NCT03856242.
References: Int Urol Nephrol. 2001;33(2):283-92. (PMID: 12092641)
Br J Urol. 1968 Feb;40(1):53-61. (PMID: 4171088)
J Physiol. 1937 Feb 19;89(1):1-13. (PMID: 16994840)
Urologiia. 2014 Nov-Dec;(6):47-8, 50. (PMID: 25799727)
Vrach Delo. 1973 Sep;9:62-4. (PMID: 4129187)
Urologiia. 2017 Jul;(3 (supplement)):4-18. (PMID: 28845924)
Urology. 2011 Nov;78(5):1063-7. (PMID: 21908022)
Urologiia. 2012 Sep-Oct;(6):84-7. (PMID: 23379246)
Khirurgiia (Mosk). 1996;(6):75-7. (PMID: 9173159)
Int J Cardiol. 2010 Oct 29;144(3):452. (PMID: 19359054)
Eur Urol. 2016 Nov;70(5):788-796. (PMID: 27451136)
فهرسة مساهمة: Keywords: Alpha-1-adrenoblockers; Benign prostatic hyperplasia (BPH); Cardiac rhythm; Holter monitoring (HM); Ischemic heart disease (IHD); Lower urinary tract symptoms (LUTS); Transurethral resection of the prostate (TURP); Voiding dysfunctions
سلسلة جزيئية: ClinicalTrials.gov NCT03856242
figshare 10.6084/m9.figshare.8046791
المشرفين على المادة: 0 (Adrenergic alpha-1 Receptor Antagonists)
0 (Urological Agents)
G3P28OML5I (Tamsulosin)
تواريخ الأحداث: Date Created: 20190601 Date Completed: 20200610 Latest Revision: 20231014
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC6822867
DOI: 10.1007/s12325-019-00977-8
PMID: 31148056
قاعدة البيانات: MEDLINE
الوصف
تدمد:1865-8652
DOI:10.1007/s12325-019-00977-8